Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yangyin Roujin Decoction is a traditional Chinese medicine (TCM) herbal compound formula being investigated for the treatment of fibromyalgia syndrome (FM). It is an empirical herbal prescription used in clinical practice to address chronic pain and associated symptoms. The formula's mechanism of action is being studied through multiple lenses, including its impact on the gut microbiota-metabolome profile and its effects on central pain processing as measured by brain MRI. The treatment aims to improve physical function and quality of life in patients with FM by alleviating physical pain and common concomitant symptoms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yangyin roujin decoction.